Skip to main content
OpenTrials

Clinical trial condition

Attention-Deficit Hyperactivity Disorder (ADHD)

Explore clinical trials studying Attention-Deficit Hyperactivity Disorder (ADHD). Study availability and eligibility vary by location and protocol.

7 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Attention-Deficit Hyperactivity Disorder (ADHD) trial results

Completed

PDC-1421 Treatment in Adult Patients With ADHD

NCT05202327

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention-Deficit Hyperactivity Disorder (ADHD), +2 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Kaohsiung Chang Gung Memorial Hospital Kaohsiung City, Taiwan
  • National Taiwan University Hospital Taipei, Taiwan
  • Cheng Hsin General Hospital Taipei, Taiwan
View Trial Details
Completed

Phase I Single Dose, Open-Label Pharmacokinetic Study and Single-Blind, Placebo-Controlled Dose Escalation Study of NFC-1 in Adolescents With Attention-Deficit Hyperactivity Disorder

NCT02286817

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention-Deficit Hyperactivity Disorder (ADHD), +2 more
Locations
  • Thomas Jefferson University, Clinical Research Unit Philadelphia, Pennsylvania, United States
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years Old With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.

NCT03231800

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention-Deficit Hyperactivity Disorder (ADHD), +2 more
Locations
  • Avida Inc Newport Beach, California, United States
  • Meridien Research Bradenton, Florida, United States
  • Meridien Research Maitland, Florida, United States
  • Qps-Mra, Llc South Miami, Florida, United States
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.

NCT02734693

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention-Deficit Hyperactivity Disorder (ADHD), +2 more
Locations
  • Avida Inc Newport Beach, California, United States
  • Meridien Research Bradenton, Florida, United States
  • Florida Clinical Research Center, LLC Maitland, Florida, United States
  • Center for Psychiatry and Behavioral Medicine, Inc. Las Vegas, Nevada, United States
View Trial Details

Related conditions